SGEN Seagen Inc

Price (delayed)

$151.52

Market cap

$27.5B

P/E Ratio

39.98

Dividend/share

N/A

EPS

$3.79

Enterprise value

$27.18B

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington , is ...

Highlights
The company's revenue has surged by 138% YoY and by 4.5% QoQ
SGEN's gross profit has soared by 126% year-on-year and by 3.2% since the previous quarter
The gross margin has decreased by 4.8% YoY

Key stats

What are the main financial stats of SGEN
Market
Shares outstanding
181.48M
Market cap
$27.5B
Enterprise value
$27.18B
Valuations
Price to earnings (P/E)
39.98
Price to book (P/B)
8.02
Price to sales (P/S)
12.08
EV/EBIT
41.02
EV/EBITDA
36.92
EV/Sales
11.96
Earnings
Revenue
$2.27B
EBIT
$662.68M
EBITDA
$736.21M
Free cash flow
$735.63M
Per share
EPS
$3.79
Free cash flow per share
$4.06
Book value per share
$18.9
Revenue per share
$12.55
TBVPS
$18.72
Balance sheet
Total assets
$3.94B
Total liabilities
$518.36M
Debt
$58.29M
Equity
$3.42B
Working capital
$2.71B
Liquidity
Debt to equity
0.02
Current ratio
7.97
Quick ratio
7.36
Net debt/EBITDA
-0.43
Margins
EBITDA margin
32.4%
Gross margin
88.9%
Net margin
29.1%
Operating margin
25.8%
Efficiency
Return on assets
20.2%
Return on equity
24.1%
Return on invested capital
35.4%
Return on capital employed
18.6%
Return on sales
29.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SGEN stock price

How has the Seagen stock price performed over time
Intraday
-1.15%
1 week
-2.62%
1 month
2.73%
1 year
-3.42%
YTD
-13.49%
QTD
9.12%

Financial performance

How have Seagen's revenue and profit performed over time
Revenue
$2.27B
Gross profit
$2.02B
Operating income
$586.79M
Net income
$660.65M
Gross margin
88.9%
Net margin
29.1%
SGEN's net margin has surged by 189% year-on-year and by 3.2% since the previous quarter
The company's operating margin has surged by 188% YoY but it fell by 6% QoQ
The company's revenue has surged by 138% YoY and by 4.5% QoQ
SGEN's gross profit has soared by 126% year-on-year and by 3.2% since the previous quarter

Growth

What is Seagen's growth rate over time

Valuation

What is Seagen stock price valuation
P/E
39.98
P/B
8.02
P/S
12.08
EV/EBIT
41.02
EV/EBITDA
36.92
EV/Sales
11.96
The EPS has increased by 8% QoQ
SGEN's equity has soared by 94% YoY
The price to book (P/B) is 32% less than the last 4 quarters average of 11.9 and 22% less than the 5-year quarterly average of 10.4
The company's revenue has surged by 138% YoY and by 4.5% QoQ
The P/S is 32% below the last 4 quarters average of 18.1 and 31% below the 5-year quarterly average of 17.7

Efficiency

How efficient is Seagen business performance
The ROS has soared by 189% YoY and by 3.2% QoQ
The ROIC has contracted by 11% from the previous quarter
Seagen's return on equity has decreased by 8% QoQ
The return on assets has declined by 7% since the previous quarter

Dividends

What is SGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGEN.

Financial health

How did Seagen financials performed over time
SGEN's total assets has surged by 89% year-on-year
The quick ratio has soared by 85% YoY
SGEN's debt is 98% smaller than its equity
SGEN's equity has soared by 94% YoY
The debt to equity has plunged by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.